Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.22%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +34.95%
#5 Humanity Humanity +26.29%
#6 Codatta Codatta +19.83%
#7 Walrus Walrus +18.24%
#8 Enso Enso +17.51%
#9 RedStone RedStone +16.76%
#10 Collector Crypt Collector Crypt +14.50%
Coin of the day
EXOD EXOD
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Blue Water Vaccines, Inc. Blue Water Vaccines, Inc.

Blue Water Vaccines, Inc.

BWV
Kedudukan dalam Saham #36371
Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to... Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases. Currently in preclinical stages, their most prominent vaccine candidates are BWV-101, an influenza shot, and BWV-102, designed to counter H1 pre-pandemic threats. The company's developmental portfolio also includes other preclinical programs such as BWV-201, a vaccine addressing acute otitis media caused by Streptococcus pneumoniae; BWV-301, a combined vaccine for norovirus and rotavirus; and BWV-302, a dual-target vaccine for norovirus and malaria. Founded in 2018, BWV's operations are based in Cincinnati, Ohio.
Harga Saham
$0.1735
Disegerakkan terakhir: 2024-01-16
Modal Pasaran
$2.76M
Perubahan (1 hari)
-3.82%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Blue Water Vaccines, Inc. (BWV)

Kategori

Healthcare
Pendapatan untuk Blue Water Vaccines, Inc. (BWV)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Blue Water Vaccines, Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Blue Water Vaccines, Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE